The FDA is currently navigating a period of upheaval, marked by notable personnel exits and internal challenges. This situation has raised questions about the agency's direction and effectiveness.
In light of these developments, former FDA commissioner David Kessler has shared his views on the agency's future. He believes that this tumultuous phase could present an opportunity for positive change.
Kessler's optimism suggests that, despite the current difficulties, the FDA may be able to realign its focus and enhance its operations moving forward.